Clinical Trials on Weber-Cockayne Syndrome

Total 34604 results

Yale University
National Institute on Drug Abuse (NIDA)

Completed

Galantamine to Enhance Cognitive Behavioral Therapy for Cocaine Abuse

Cocaine Dependence

United States
ANRS, Emerging Infectious Diseases
Hopital Paul Brousse

Withdrawn

Methylphenidate for Cocaine Dependence (ANRS STIMAGO)

Substance-Related Disorders

France
Medical University of South Carolina

Completed

Effect of Oxytocin on Stress Response in Cocaine-dependent Individuals

Cocaine Dependence

United States
New York State Psychiatric Institute

Completed

Imaging the Neurobiology of Behavioral and Medication Treatment for Cocaine Dependence (COST)

Cocaine Dependence

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA); Columbia University

Completed

Behavioral and Physiological Effects of Cocaine in Cocaine-dependent Participants Treated With Levodopa in Combination With Carbidopa and Entacapone (LCE) (COST)

Cocaine Abuse

United States
Medical University of South Carolina

Completed

Ovarian Hormones and Stress Induced Drug Craving

Cocaine Dependence

United States
Virginia Commonwealth University
National Institute on Drug Abuse (NIDA)

Completed

Striatal Effective Connectivity to Predict Treatment Response in Cocaine Misuse

Cocaine Dependence

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Completed

Modafinil for Smoked Cocaine Self-Administration

Cocaine Dependence

United States
Virginia Commonwealth University
National Institute on Drug Abuse (NIDA); The University of Texas Health Science...

Completed

Brain Function and Structure in Cocaine Dependence

Cocaine Dependence

United States
New York State Psychiatric Institute

Completed

Therapeutic Cocaine Vaccine: Human Laboratory Study

Cocaine Dependence

United States
Johns Hopkins University
National Institute on Drug Abuse (NIDA)

Completed

Effect of Zonisamide on Cocaine Reinforcement, Craving, and Relapse

Cocaine Dependence

United States
The University of Texas Health Science Center,...

Completed

Psychopharmacology for Cocaine Dependence - Buspirone

Cocaine Dependence

United States
Baylor College of Medicine
National Institute on Drug Abuse (NIDA); Johns Hopkins University; University... and other collaborators

Completed

Multisite Controlled Trial of Cocaine Vaccine (TA-CD)

Cocaine Dependence

United States
National Institute on Drug Abuse (NIDA)

Completed

Study to Assess Potential Interactions Between Intravenous Cocaine and Oral Lorcaserin

Cocaine Abuse

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Completed

Imaging the Neurobiology of a Behavioral Treatment for Cocaine Dependence (PET-CRA)

Cocaine Dependence

United States
University of Minnesota

Completed

Treatment of Cocaine Dependence With Lisdexamfetamine

Cocaine Dependence

United States
Yale University
National Institute on Drug Abuse (NIDA)

Terminated

The Effects of GABA Enhancing Medications on Individuals Addicted to Cocaine - 3

Cocaine-Related Disorders | Cocaine Abuse

United States
Yale University
National Institute on Drug Abuse (NIDA)

Completed

CBT With Disulfiram and Contingency Management

Cocaine Abuse

United States
Theresa Winhusen

Withdrawn

D-Serine for Cocaine Dependence Pilot (STED-CD)

Cocaine Dependence

United States
Jennifer Plebani
National Institute on Drug Abuse (NIDA)

Withdrawn

Human Behavioral Pharmacology Laboratory Study of Varenicline's Impact on Cocaine Reinforcement

Cocaine Dependence

United States
Fundació Institut de Recerca de l'Hospital de la...

Completed

Exercise as an Adjunctive Treatment for Cocaine Dependent Patients

Cocaine Dependence

Spain
Medical University of South Carolina
National Institute on Drug Abuse (NIDA)

Completed

Beta-blockade Effects on Memory for Cocaine Craving

Cocaine Dependence

United States
UConn Health
National Institute on Drug Abuse (NIDA)

Completed

Vouchers vs. Prizes for Cocaine-Dependent Methadone Patients - 2

Cocaine Dependence

United States
University of Kentucky
National Institute on Drug Abuse (NIDA)

Completed

Agonist Replacement Therapy for Cocaine Dependence

Cocaine Dependence

United States
Hospital Universitari Vall d'Hebron Research Institute

Unknown

Efficacy of Caffeine, With and Without Biperiden, as a Maintenance Treatment for Cocaine Dependence

Cocaine Dependence

Spain
RTI International
National Institute on Drug Abuse (NIDA)

Completed

Safety, Tolerability, and Pharmacokinetics of Single, Escalating Oral Doses of RTI-336 in Healthy, Male Subjects

Cocaine Dependence

United States
The University of New South Wales
St Vincent's Hospital, Sydney; Australian Government Department of Health and... and other collaborators

Unknown

Randomised Placebo-Controlled Trial of Modafinil for Cocaine Dependence

Cocaine Dependence

Australia
Wayne State University
National Institute on Drug Abuse (NIDA)

Completed

Treatment Study: Reducing Cocaine/Heroin Abuse With SR-Amphetamine and Buprenorphine (ARC) (ARC)

Opioid-Related Disorders | Heroin Dependence | Cocaine Abuse or Dependence

United States
Rigel Pharmaceuticals

Recruiting

Study of R289 in Participants With Lower-risk Myelodysplastic Syndromes (LR MDS)

Low Risk Myelodysplastic Syndromes

United States
Bristol-Myers Squibb

Active, not recruiting

Real-World Practice Patterns and Outcomes of Lower-Risk Myelodysplastic Syndrome Patients in Japan

Lower-risk Myelodysplastic Syndromes

Japan
The University of Texas Health Science Center,...

Recruiting

Identifying Correlates of Brain Microglial Activation in Neuropsychiatric Syndromes: A Dimensional Approach

Neuropsychiatric Syndromes

United States
Sumitomo Pharma America, Inc.

Terminated

A Study of TP-0184 to Treat Anemia in Adults With IPSS-R Low or Intermediate Risk MDS

Anemia in Myelodysplastic Syndromes

United States
The University of Texas Health Science Center,...
National Institute on Drug Abuse (NIDA)

Completed

PPARγ Agonist Treatment for Cocaine Dependence

Alcohol Use Disorder | Cocaine Use Disorder

United States
Medical University of South Carolina
National Institute on Drug Abuse (NIDA)

Completed

Stress and Medication Effects on Cocaine Cue Reactivity

Cocaine Related Disorders

United States
National Institute on Drug Abuse (NIDA)

Terminated

Interactions Between Intravenous (IV) Cocaine and Lofexidine

Cocaine Related Disorders

United States
Groupe Francophone des Myelodysplasies

Unknown

Treatment of the Anemia of Myelodysplastic Syndromes by the Association of Epoetin Beta and All Trans Retinoic Acid

Anemia in Myelodysplastic Syndromes

France
Weill Medical College of Cornell University
National Institute on Drug Abuse (NIDA)

Recruiting

Safety Study of a Disrupted Adenovirus (Ad) Serotype Cocaine Vaccine for Cocaine-dependent Individuals

Cocaine Dependence

United States
Boston University

Completed

Efficacy of Mirtazapine in Depressed Cocaine Dependent Subjects

Depression | Cocaine Dependence

United States
Johns Hopkins University
National Institute on Drug Abuse (NIDA)

Completed

Improving Learning-based Treatment of Cocaine Dependence With Medication

COCAINE-RELATED DISORDERS

United States
National Institute on Drug Abuse (NIDA)

Completed

Buprenorphine Naltrexone-P1 A-Cocaine

Cocaine-related Disorders

United States
The Champ Foundation
Children's Hospital of Philadelphia; The Cleveland Clinic

Recruiting

SLSMDS Natural History Study

Pearson Syndrome | Single Large Scale Mitochondrial DNA Deletion Syndromes (SLSMDS)

United States
Brian Jonas
National Cancer Institute (NCI); Celgene; Pharmacyclics LLC.

Completed

Ibrutinib and Lenalidomide in Treating Patients With Myelodysplastic Syndrome

Previously Treated Myelodysplastic Syndrome | Myelodysplastic Syndrome | Therapy-Related Myelodysplastic Syndrome | Secondary Myelodysplastic Syndrome | Refractory High Risk Myelodysplastic Syndrome

United States
GenSight Biologics

Completed

RESCUE and REVERSE Long-term Follow-up (RESTORE)

Leber Hereditary Optic Neuropathy

United States, France, Italy, United Kingdom, Germany
GenSight Biologics

Active, not recruiting

Efficacy & Safety Study of Bilateral IVT Injection of GS010 in LHON Subjects Due to the ND4 Mutation for up to 1 Year (REFLECT)

Leber Hereditary Optic Neuropathy

Belgium, Spain, United States, France, United Kingdom, Taiwan, Italy
GenSight Biologics

Completed

REALITY LHON Registry (REALITY)

Leber Hereditary Optic Neuropathy

United States, France, Italy, Spain, United Kingdom
Huazhong University of Science and Technology
Shiyan Taihe Hospital

Active, not recruiting

A Single Intravitreal Injection of rAAV2-ND4 for the Treatment of Leber's Hereditary Optic Neuropathy

Leber Hereditary Optic Neuropathy

China
GenSight Biologics

Completed

Safety Evaluation of Gene Therapy in Leber Hereditary Optic Neuropathy (LHON) Patients

Leber Hereditary Optic Neuropathy

France
Santhera Pharmaceuticals
European Vision Institute Clinical Research Network

Completed

Leber Hereditary Optic Neuropathy (LHON) Historical Case Record Survey

Leber Hereditary Optic Neuropathy (LHON)

Belgium, France, Denmark, Italy, Slovenia
University of Pennsylvania

Active, not recruiting

Evaluation of D3 Receptor Occupancy Using FLUORTRIOPRIDE ([18F]FTP) PET/CT

Healthy Volunteer | D3 Dopamine Receptor | Cocaine-dependent

United States
Laboratoire de Psychologie des Cognitions
University Hospital, Strasbourg, France; ICube Laboratory - Team IGG; Ithaque... and other collaborators

Completed

Virtual Reality Exposure and Respiratory Relaxation-Based Coping With Cocaine Craving in Cocaine Users (RVCOC)

Cocaine Use Disorder | Virtual Reality Exposure Therapy

France

Clinical Trials on Weber-Cockayne Syndrome

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Germany

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations